title: Bulimia nervosa among methamphetamine dependent adults: association with outcomes three years after treatment.
abstract: Although weight loss is among the most commonly cited reasons for using methamphetamine (MA), little is known about the association between eating disorders and treatment outcomes in this population. This study examined psychiatric, substance use, and functional outcomes of MA users (N = 526) with bulimia nervosa 3 years after treatment for MA dependence. Bulimia nervosa was observed among 2.4% (N = 13) of the participants and was associated with poorer MA use outcomes, increased health service utilization, and higher levels of functional impairment. Addressing MA use among adults with eating disorders may be helpful as a means of improving treatment outcomes.
authors.affiliation: Integrated Substance Abuse Programs, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90024, USA. sglasner@ucla.edu
authors.forename: Suzette
authors.initials: S
authors.lastname: Glasner-Edwards
authors.forename: Larissa J
authors.initials: LJ
authors.lastname: Mooney
authors.forename: Patricia
authors.initials: P
authors.lastname: Marinelli-Casey
authors.forename: Maureen
authors.initials: M
authors.lastname: Hillhouse
authors.forename: Alfonso
authors.initials: A
authors.lastname: Ang
authors.forename: Richard
authors.initials: R
authors.lastname: Rawson
mesh_terms: D000328:Adult; D019969:Amphetamine-Related Disorders / Q000453:epidemiology / Q000523:psychology* / Q000628:therapy*; D052018:Bulimia Nervosa / Q000453:epidemiology / Q000523:psychology*; D015897:Comorbidity; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D011569:Psychiatric Status Rating Scales; D012720:Severity of Illness Index; D013997:Time Factors; D016896:Treatment Outcome